Skip to content

Nuvalent, Inc. NUVL Return on equity

Return on equity at other companies

Pfizer logo
PfizerPFE
10.6%
Summit Therapeutics logo
Summit TherapeuticsSMMT
-271%-1,725pp
Exelixis logo
ExelixisEXEL
41%+10.8pp
Revolution Medicines, Inc. logo
Revolution Medicines, Inc.RVMD
-76.7%-923pp
Incyte logo
IncyteINCY
30.8%+30.4pp
ALN
Alnylam PharmaceuticalsALNY
66.9%

Other financials

Income statement

See full
Operating income-$119.4M-25.9%
Net income-$109.3M-29.2%
EPS (diluted)-$1.39-17.8%

Balance sheet

See full
Cash & equivalents$159.7M+32.2%
Total equity$1.2B+16.2%
Total assets$1.3B+20.4%

Cash flow

See full
Operating cash flow-$92.4M-68.5%

Valuation

See full
Market cap$9.77B+58.6%

Returns & leverage

See full
Current ratio16.1×+1.7×

Where this comes from

Calculated from Nuvalent, Inc.’s reported figures.

Based on trailing twelve months.

The official record: Nuvalent, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Nuvalent, Inc.'s return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Nuvalent, Inc.'s return on equity?
Nuvalent, Inc. (NUVL) reported return on equity of -41.2% in Q1 2026.
How has Nuvalent, Inc.'s return on equity changed year-over-year?
Nuvalent, Inc.'s return on equity decreased by 15.4% year-over-year, from -35.7% to -41.2%.
What is the long-term trend for Nuvalent, Inc.'s return on equity?
Over 3 years (2022 to 2025), Nuvalent, Inc.'s return on equity has grown at a 18.8% compound annual growth rate (CAGR), from -21.9% to -36.7%.
What does return on equity mean?
How much profit the company earns on the money shareholders have invested.
How do you interpret return on equity?
Higher is better, but very high ROE can be manufactured by leverage — a thin equity base inflates the ratio. Read it next to debt-to-equity and ROIC to tell genuine returns from balance-sheet engineering.
How does return on equity compare across companies?
Comparable across peers, with the leverage caveat. Negative or near-zero equity makes ROE meaningless, so it is suppressed there.